{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013942","form_type":"8-K","ticker":"BMRA","cik":"0000073290","company_name":"BIOMERICA INC","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.130377+00:00","generated_at":"2026-05-19T18:57:49.797484+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biomerica appoints Eric Chin to board; Cathy Coste resigns effective June 4","bullets":["Cathy Coste resigned as director effective June 4, 2025; no disagreement with the company.","Eric Chin appointed as independent director and Audit Committee Chair, effective same date.","Chin is CFO of Akido Labs, helped raise $60M; will receive $41K annual cash and 10,000 restricted shares.","Chin also joins Nominating/Governance and Compensation Committees.","No family relationships or transactions requiring disclosure; board determined independent per Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013942","json":"https://secwatch.observer/filing/0001641172-25-013942.json","markdown":"https://secwatch.observer/filing/0001641172-25-013942.md","text":"https://secwatch.observer/filing/0001641172-25-013942.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/73290/000164117225013942/0001641172-25-013942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/73290/000164117225013942/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:57:49.797484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09bc2fc797","claim":"Eric Chin was appointed as Director and Audit Committee Chair at BIOMERICA INC.","evidence_excerpt":"On the same date, the Board appointed Mr. Eric Chin to serve as an independent member of the Board, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000164117225013942/0001641172-25-013942-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Audit Committee Chair"}],"fact_type":"executive_change"},{"claim_id":"a6ca26070b","claim":"Cathy Coste resigned as Director at BIOMERICA INC.","evidence_excerpt":"Effective June 4, 2025, Ms. Cathy Coste stepped down as a member of the Board of Directors","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000164117225013942/0001641172-25-013942-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}